Follow
Vesna Blazevic
Vesna Blazevic
Head of Laboratory, Group Leader-Vaccine Development Unit, Vaccine Research Center, Tampere
Verified email at tuni.fi
Title
Cited by
Cited by
Year
Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis
V Blazevic, S Lappalainen, K Nurminen, L Huhti, T Vesikari
Vaccine 29 (45), 8126-8133, 2011
1402011
Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3, the Human UNC-53 Homologue
L Karenko, S Hahtola, S Päivinen, R Karhu, S Syrjä, M Kähkönen, ...
Cancer research 65 (18), 8101-8110, 2005
1212005
Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice
K Tamminen, S Lappalainen, L Huhti, T Vesikari, V Blazevic
PloS one 8 (7), e70409, 2013
1052013
A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles
L Huhti, V Blazevic, K Nurminen, T Koho, VP Hytönen, T Vesikari
Archives of virology 155, 1855-1858, 2010
1052010
Prevalence of norovirus GII‐4 antibodies in Finnish children
K Nurminen, V Blazevic, L Huhti, S Räsänen, T Koho, VP Hytönen, ...
Journal of medical virology 83 (3), 525-531, 2011
972011
A comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particles
K Tamminen, L Huhti, T Koho, S Lappalainen, VP Hytönen, T Vesikari, ...
Immunology 135 (1), 89-99, 2012
932012
High serum levels of norovirus genotype–specific blocking antibodies correlate with protection from infection in children
M Malm, H Uusi-Kerttula, T Vesikari, V Blazevic
The Journal of infectious diseases 210 (11), 1755-1762, 2014
862014
Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children
L Huhti, ED Szakal, L Puustinen, M Salminen, H Huhtala, O Valve, ...
Journal of Infectious Diseases 203 (10), 1442-1444, 2011
832011
Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009–2010
L Puustinen, V Blazevic, M Salminen, M Hämäläinen, S Räsänen, ...
Scandinavian journal of infectious diseases 43 (10), 804-808, 2011
762011
Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007
L Puustinen, V Blazevic, L Huhti, ED Szakal, A Halkosalo, M Salminen, ...
Epidemiology & Infection 140 (2), 268-275, 2012
662012
Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
S Lappalainen, AR Pastor, M Malm, V López-Guerrero, ...
Archives of virology 160, 2075-2078, 2015
572015
His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display
T Koho, TO Ihalainen, M Stark, H Uusi-Kerttula, R Wieneke, R Rahikainen, ...
European Journal of Pharmaceutics and Biopharmaceutics 96, 22-31, 2015
562015
Production and characterization of virus-like particles and the P domain protein of GII. 4 norovirus
T Koho, L Huhti, V Blazevic, K Nurminen, SJ Butcher, P Laurinmäki, ...
Journal of virological methods 179 (1), 1-7, 2012
562012
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo
S Lappalainen, AR Pastor, K Tamminen, V López-Guerrero, ...
Human vaccines & immunotherapeutics 10 (7), 2039-2047, 2014
552014
Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation
LA Pinto, V Blazevic, BK Patterson, C Mac Trubey, MJ Dolan, GM Shearer
Journal of virology 74 (10), 4505-4511, 2000
492000
Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles
S Lappalainen, K Tamminen, T Vesikari, V Blazevic
Human vaccines & immunotherapeutics 9 (9), 1991-2001, 2013
432013
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH
M Malm, E Rollman, M Ustav, J Hinkula, K Krohn, B Wahren, V Blazevic
Viral immunology 18 (4), 678-688, 2005
412005
Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays
H Uusi-Kerttula, K Tamminen, M Malm, T Vesikari, V Blazevic
Microbes and Infection 16 (6), 472-480, 2014
382014
Rapid and sensitive detection of norovirus antibodies in human serum with a biolayer interferometry biosensor
S Auer, T Koho, H Uusi-Kerttula, T Vesikari, V Blazevic, VP Hytönen
Sensors and Actuators B: Chemical 221, 507-514, 2015
372015
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine
V Blazevic, M Malm, D Arinobu, S Lappalainen, T Vesikari
Human vaccines & immunotherapeutics 12 (3), 740-748, 2016
352016
The system can't perform the operation now. Try again later.
Articles 1–20